Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982;45(1-2):269-76.
doi: 10.1007/BF00235787.

Changes in brain blood flow associated with deltamethrin-induced choreoathetosis in the rat

Changes in brain blood flow associated with deltamethrin-induced choreoathetosis in the rat

D E Ray. Exp Brain Res. 1982.

Abstract

Deltamethrin is a pyrethroid insecticide which produces reversible motor symptoms in mammals involving facial movements, progressive incoordination, and choreoathetosis. These symptoms were found to be preceded and accompanied by increases in blood flow in the caudate nucleus and cerebral cortex of conscious rats. Blood flow, measured by the hydrogen polarography method, showed a 2.8-3.8 fold increase in the caudate nucleus and a 1.9-2.6 increase in the cortex after intraperitoneal deltamethrin. The increase in caudate blood flow provided an early and sensitive indicator of the development of motor symptoms, and preceded development of EEG spike discharges. A different pattern of motor symptoms consisting largely of tremor with no choreoathetosis was produced for comparison using another pyrethroid, cismethrin. This, whilst producing a similar increase in cortical flow, did not produce the disproportionate increase in caudate flow characteristic of deltamethrin. Although the actions of deltamethrin were shown not to be restricted to the extrapyramidal system, the selectivity of the blood flow increases, and the nature of the symptoms produced show deltamethrin to be a useful tool for the production of experimental extrapyramidal motor hyperactivity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Physiol. 1964 Jan;206:25-35 - PubMed
    1. Acta Neurol Scand Suppl. 1965;14:46-52 - PubMed
    1. Eur J Pharmacol. 1979 Oct 15;58(4):501-4 - PubMed
    1. Circ Res. 1968 Aug;23 (2):313-24 - PubMed
    1. Stroke. 1973 Jul-Aug;4(4):556-67 - PubMed

LinkOut - more resources